• 18 Citations
  • 3 h-Index
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2019

  • 18 Citations
  • 3 h-Index
  • 11 Article
  • 4 Review article
Review article
1 Citation (Scopus)

Anti-PD-1 versus anti-PD-L1 therapy in patients with pretreated advanced non-small-cell lung cancer: A meta-analysis

Tartarone, A., Roviello, G., Lerose, R., Roudi, R., Aieta, M. & Zoppoli, P., Jul 1 2019, In : Future Oncology. 15, 20, p. 2423-2433 11 p.

Research output: Contribution to journalReview article

Non-Small Cell Lung Carcinoma
Disease-Free Survival
4 Citations (Scopus)

Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer

Sobhani, N., Generali, D., D’Angelo, A., Aieta, M. & Roviello, G., Dec 1 2018, In : Investigational New Drugs. 36, 6, p. 1133-1137 5 p.

Research output: Contribution to journalReview article

Androgen Receptors
Prostatic Neoplasms

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

Sobhani, N., Ianza, A., D'Angelo, A., Roviello, G., Giudici, F., Bortul, M., Zanconati, F., Bottin, C. & Generali, D., Jul 15 2018, In : Cells. 7, 7

Research output: Contribution to journalReview article

Fibroblast Growth Factor Receptors
Breast Neoplasms
Fibroblast Growth Factors
Precision Medicine
Second Primary Neoplasms

Lenvatinib for the treatment of renal cell carcinoma

Roviello, G., Corona, S. P., Bozza, G., Aieta, M., Generali, D., Rodriquenz, M. G., Mileo, A. M., Imperatori, M., Ianza, A., Conca, R. & Sobhani, N., May 2018, In : Expert Opinion on Investigational Drugs. 27, 5, p. 507-512 6 p.

Research output: Contribution to journalReview article

Renal Cell Carcinoma
Vascular Endothelial Growth Factor Receptor
Expert Testimony